Search
for
Sort by
Research 61–90 of 1000+
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- The ginseng pimple: an inflammatory papule following ginseng consumption
- Mucocutaneous findings in hematolymphoid neoplasms: An observational study
- Psoriasiform drug eruption to finasteride: Uncommon side effect of a commonly used drug
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- TOXIC EPIDERMAL NECROLYSIS
- A Case of Cicatricial Alopecia Associated with Erlotinib
- Extracellular Vesicles: Emerging Therapeutics in Cutaneous Lesions
- Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database
- 4. Bullous/Mucous Membrane
- Oral Presentations
- The pharmacology of methotrexate
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study
- Ponatinib-induced pityriasis rubra pilaris-like adnexal dysmaturation: A case report
- Reporting on Adverse Clinical Events
- Winding the clock back on female androgenetic alopecia
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Contents
- Relapsing Course of Sulfasalazine-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Complicated by Alopecia Universalis and Vitiligo
- Adverse cutaneous reactions to soft tissue fillers – a review of the histological features
- Cutaneous reactions to recombinant cytokine therapy
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system
- HHV-6A and HHV-6B in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Drug Reactions Affecting Hair: Diagnosis
- Cutaneous Reactions in Patients with Chronic Hepatitis C Treated with Peginterferon and Ribavirin
- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study
- Disease modifying agent related skin reactions in multiple sclerosis: prevention, assessment, and management